112 related articles for article (PubMed ID: 11532018)
41. Regulation of interleukin 4-mediated signaling by naturally occurring dominant negative and attenuated forms of human Stat6.
Patel BK; Pierce JH; LaRochelle WJ
Proc Natl Acad Sci U S A; 1998 Jan; 95(1):172-7. PubMed ID: 9419348
[TBL] [Abstract][Full Text] [Related]
42. Activation of STAT5 by IL-4 relies on Janus kinase function but not on receptor tyrosine phosphorylation, and can contribute to both cell proliferation and gene regulation.
Friedrich K; Kammer W; Erhardt I; Brändlein S; Sebald W; Moriggl R
Int Immunol; 1999 Aug; 11(8):1283-94. PubMed ID: 10421786
[TBL] [Abstract][Full Text] [Related]
43. Induction of 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene transcription in human breast cancer cell lines and in normal mammary epithelial cells by interleukin-4 and interleukin-13.
Gingras S; Moriggl R; Groner B; Simard J
Mol Endocrinol; 1999 Jan; 13(1):66-81. PubMed ID: 9892013
[TBL] [Abstract][Full Text] [Related]
44. Stat6-protease but not Stat5-protease is inhibited by an elastase inhibitor ONO-5046.
Suzuki K; Nakajima H; Ikeda K; Tamachi T; Hiwasa T; Saito Y; Iwamoto I
Biochem Biophys Res Commun; 2003 Oct; 309(4):768-73. PubMed ID: 13679038
[TBL] [Abstract][Full Text] [Related]
45. Identification of a STAT6 domain required for IL-4-induced activation of transcription.
Lu B; Reichel M; Fisher DA; Smith JF; Rothman P
J Immunol; 1997 Aug; 159(3):1255-64. PubMed ID: 9233621
[TBL] [Abstract][Full Text] [Related]
46. Differential effects of interleukin-3 and interleukin-1 on the proliferation and interleukin-6 protein secretion of acute myeloid leukemic cells; the involvement of ERK, p38 and STAT5.
Birkenkamp KU; Esselink MT; Kruijer W; Vellenga E
Eur Cytokine Netw; 1999 Dec; 10(4):479-90. PubMed ID: 10586114
[TBL] [Abstract][Full Text] [Related]
47. Synergistic activation of the germline epsilon promoter mediated by Stat6 and C/EBP beta.
Mikita T; Kurama M; Schindler U
J Immunol; 1998 Aug; 161(4):1822-8. PubMed ID: 9712049
[TBL] [Abstract][Full Text] [Related]
48. Phytochemical inhibition of interleukin-4-activated Stat6 and expression of VCAM-1.
Schnyder B; Schnyder-Candrian S; Panski A; Bömmel H; Heim M; Duschl A; Moser R
Biochem Biophys Res Commun; 2002 Apr; 292(4):841-7. PubMed ID: 11944890
[TBL] [Abstract][Full Text] [Related]
49. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
[TBL] [Abstract][Full Text] [Related]
50. CD45 tyrosine phosphatase controls common gamma-chain cytokine-mediated STAT and extracellular signal-related kinase phosphorylation in activated human lymphoblasts: inhibition of proliferation without induction of apoptosis.
Blank N; Kriegel M; Hieronymus T; Geiler T; Winkler S; Kalden JR; Lorenz HM
J Immunol; 2001 May; 166(10):6034-40. PubMed ID: 11342620
[TBL] [Abstract][Full Text] [Related]
51. Antiinflammatory properties of a peptide derived from interleukin-4.
Klementiev B; Enevoldsen MN; Li S; Carlsson R; Liu Y; Issazadeh-Navikas S; Bock E; Berezin V
Cytokine; 2013 Oct; 64(1):112-21. PubMed ID: 23972727
[TBL] [Abstract][Full Text] [Related]
52. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
Lejeune D; Demoulin JB; Renauld JC
Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
[TBL] [Abstract][Full Text] [Related]
53. Functional synergism of STAT6 with either NF-kappa B or PU.1 to mediate IL-4-induced activation of IgE germline gene transcription.
Stütz AM; Woisetschläger M
J Immunol; 1999 Oct; 163(8):4383-91. PubMed ID: 10510379
[TBL] [Abstract][Full Text] [Related]
54. Analysis of the life cycle of stat6. Continuous cycling of STAT6 is required for IL-4 signaling.
Andrews RP; Ericksen MB; Cunningham CM; Daines MO; Hershey GK
J Biol Chem; 2002 Sep; 277(39):36563-9. PubMed ID: 12121972
[TBL] [Abstract][Full Text] [Related]
55. Interleukin-4 induces two distinct GAS-binding complexes containing STAT6: evidence for DNA binding of STAT6 monomer.
Lee CE; Park HJ
Mol Cells; 2001 Feb; 11(1):28-34. PubMed ID: 11266117
[TBL] [Abstract][Full Text] [Related]
56. Interleukin-4-induced STAT6 recognizes and activates a target site in the promoter of the interleukin-4 receptor gene.
Kotanides H; Reich NC
J Biol Chem; 1996 Oct; 271(41):25555-61. PubMed ID: 8810328
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of transforming growth factor-beta signaling by low molecular weight compounds interfering with ATP- or substrate-binding sites of the TGF beta type I receptor kinase.
Yakymovych I; Engström U; Grimsby S; Heldin CH; Souchelnytskyi S
Biochemistry; 2002 Sep; 41(36):11000-7. PubMed ID: 12206672
[TBL] [Abstract][Full Text] [Related]
58. Assessment of signal transducer and activator of transcription 6 as a target of glucocorticoid action in human airway epithelial cells.
Heller NM; Matsukura S; Georas SN; Boothby MR; Stellato C; Schleimer RP
Clin Exp Allergy; 2004 Nov; 34(11):1690-700. PubMed ID: 15544592
[TBL] [Abstract][Full Text] [Related]
59. Characterization of the interleukin-4 receptor complex in human corneal fibroblasts.
Fukuda K; Fujitsu Y; Kumagai N; Nishida T
Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):183-8. PubMed ID: 11773030
[TBL] [Abstract][Full Text] [Related]
60. IFN-gamma-induced SOCS-1 regulates STAT6-dependent eotaxin production triggered by IL-4 and TNF-alpha.
Sato T; Saito R; Jinushi T; Tsuji T; Matsuzaki J; Koda T; Nishimura Si; Takeshima H; Nishimura T
Biochem Biophys Res Commun; 2004 Feb; 314(2):468-75. PubMed ID: 14733929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
